UCSF Diabetes, Brain Tumor Stem Cell Grants To Drive Development Of Therapies

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors. The intent of the grants is for teams to file new drug applications to the U.S. Food and Drug Administration within four years, driving potential therapies toward clinical trials. The two grants, awarded to collaborative scientific teams, total $39.2 million.

[Read the full article here]

Leave a Reply